Literature DB >> 16987800

Delta-thalassemia in Cyprus.

Eleni Pavlou1, Marios Phylactides, Andriani Kyrri, Eleni Kalogerou, Christiana Makariou, Ioannis Georgiou, Marina Kleanthous.   

Abstract

To help clarify the hematological picture of patients who may be positive for beta- and delta-globin gene mutations, the following study was carried out. Our aim was to identify the delta-globin gene mutations found in the Greek Cypriot population, their frequencies and the Hb A2 values associated with them. Seventy-four samples were selected from a random sample of 5,030 individuals, and the database of the Molecular Genetics Thalassaemia Department containing diagnostic analyses data was also mined for relevant information. Four novel for Cyprus delta-globin gene mutations: -30 (T-->C), Hb A2-Wrens [delta98(FG5)Val-->Met, GTG-->ATG], IVS-I-2 (T-->C) and Hb A2-Yokoshima [delta25(B7)Gly-->Asp (GGT-->GAT)] were identified. Hb A2-Yialousa [delta27(B9)Ala-->Ser, GCC-->TCC], Hb A2-Yokoshima, Hb A2-Troodos [delta116(G18)Arg-->Cys, CGC-->TGC], Hb A2-Pelendri [delta141(H19)Leu-->Pro, CTG-->CCG], codon 4 [delta4(A1)Thr-->Ile], codon 59 (-A), Hb A2-Wrens, IVS-II-897 (A-->G), IVS-I-2, -55 (T-->C) and -30 bring the total to 11 delta-globin alleles found in the Greek Cypriot population. Hb A2-Yialousa is the most common mutation followed by codon 4, with frequencies of 60.7 and 17.8%, respectively.Hb A2 levels above 1.9% have been found to indicate a significantly reduced possibility for the presence of a delta-globin gene mutation in this population. For Hb A2 levels of 1.7 and 1.8% the possibility of a delta-globin gene mutation rises to 90.9% and reaches 100% for lower Hb A2 levels. The frequency of all the mutant delta-globin chromosomes in the sample is 0.0067 and the carrier frequency is 1.26%.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16987800     DOI: 10.1080/03630260600868006

Source DB:  PubMed          Journal:  Hemoglobin        ISSN: 0363-0269            Impact factor:   0.849


  4 in total

1.  First reported case of compound heterozygosity for HbA2-Yialousa (HBD: c.82 G>C) and HbA2-Wrens (HBD: c.295 G>A) in Oman.

Authors:  Shoaib Al Zadjali; Wafa Bashir; David Gravell; Arwa Z Al Riyami; Yasser Wali; Shahina Daar
Journal:  Int J Hematol       Date:  2013-08       Impact factor: 2.490

2.  Hb Knossos (HBB: c.82G > T), β-globin CD 5 (-CT) (HBB: c.17_18delCT) and δ-globin CD 59 (-a) (HBD: c.179delA) mutations in a Syrian patient with β-thalassemia intermedia.

Authors:  Faten Moassas; Mohamad Sayah Nweder; Hossam Murad
Journal:  BMC Pediatr       Date:  2019-02-18       Impact factor: 2.125

3.  HbA2-Yokoshima (delta 25(B7)Gly >Asp) and Hb A2-Yialousa (delta 27(B9)Ala>Ser) in Turkey.

Authors:  Aylin Köseler; Ayfer Atalay; Erol Ömer Atalay
Journal:  Turk J Haematol       Date:  2012-10-05       Impact factor: 1.831

4.  The molecular spectrum and distribution of haemoglobinopathies in Cyprus: a 20-year retrospective study.

Authors:  Petros Kountouris; Ioanna Kousiappa; Thessalia Papasavva; George Christopoulos; Eleni Pavlou; Miranda Petrou; Xenia Feleki; Eleni Karitzie; Marios Phylactides; Pavlos Fanis; Carsten W Lederer; Andreani R Kyrri; Eleni Kalogerou; Christiana Makariou; Christiana Ioannou; Loukas Kythreotis; Georgia Hadjilambi; Nicoletta Andreou; Evangelia Pangalou; Irene Savvidou; Michael Angastiniotis; Michael Hadjigavriel; Maria Sitarou; Annita Kolnagou; Marina Kleanthous; Soteroula Christou
Journal:  Sci Rep       Date:  2016-05-20       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.